Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Intestine Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07542704
What this trial is testing

Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid TumorsColorectal Cancer (CRC)Non-Small Cell Lung Cancer+3 more
Kumquat Biosciences Inc. 48
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Early research (Phase 1)Study completedNCT01434069
What this trial is testing

Phase I Trial of Combination of FOLFIRI and SOM 230

Who this might be right for
Gastrointestinal Tumor
H. Lee Moffitt Cancer Center and Research Institute 16
Early research (Phase 1)Ended earlyNCT02659631
What this trial is testing

PF-06671008 Dose Escalation Study in Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 28
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT00006039
What this trial is testing

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT06131398
What this trial is testing

AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 77
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Early research (Phase 1)Study completedNCT00006009
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Stanford University
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Ended earlyNCT05769959
What this trial is testing

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Who this might be right for
Renal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more
Hoffmann-La Roche 3
Not applicableUnknownNCT01254591
What this trial is testing

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+2 more
University College London (UCL) Cancer Institute 500
Not applicableStudy completedNCT02009774
What this trial is testing

Accuracy of the Optical Diagnosis of Small Colonic Polyps Using the Nice Classification

Who this might be right for
Colon AdenomaColorectal CarcinomaHyperplastic Polyp
Technical University of Munich 380
Testing effectiveness (Phase 2)Study completedNCT00005080
What this trial is testing

506U78 in Treating Patients With Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaRecurrent Adult T-cell Leukemia/Lymphoma+11 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Looking for participantsNCT04930432
What this trial is testing

Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+1 more
Betta Pharmaceuticals Co., Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Early research (Phase 1)Looking for participantsNCT03819296
What this trial is testing

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+41 more
M.D. Anderson Cancer Center 800
Early research (Phase 1)Looking for participantsNCT07630961
What this trial is testing

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)+4 more
Novartis Pharmaceuticals 66
Early research (Phase 1)Study completedNCT04319757
What this trial is testing

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more
Acepodia Biotech, Inc. 12
Next Page